首頁 > 市場調查報告書 > 製藥

非專利藥生技仿製藥

市場調查報告書

商品編碼

1705641

生物相似契約製造市場：按產品類型、按應用、按類型、按服務類型、按最終用戶、按地區

Biosimilar Contract Manufacturing Market, By Product Type, By Application, By Type, By Service Type , By End User, By Geography

出版日期: 2025年02月06日 | 出版商:

Coherent Market Insights | 英文 157 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球生物相似契約製造市場規模估計為 124.2 億美元，預計到 2032 年將達到 353.5 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 16.1%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	124.2億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	16.10%	2032年價值預測	353.5億美元

數字。 2025年生物相似契約製造市場佔有率（按地區分類）

生物相似藥是一種生物製藥具有與已核准的生物製品（稱為參考產品或原創產品）非常相似的治療效果的生物製藥。隨著幾種重磅生物製藥的專利到期，生物相似藥為患者提供了獲得更便宜的醫療保健的機會。受託製造廠商(CMO) 協助製藥公司開發和擴大生物相似藥製造流程，以生產符合嚴格品質標準的生物相似藥。透過將生物相似藥的生產外包給 CMO，製藥商可以專注於其核心競爭力，例如研發。

市場動態：

全球生物相似藥契約製造市場的成長是由生技藥品藥物專利到期導致對廉價生物學名藥的需求不斷增加，以及由於生物學名藥的成本效益而對生物學名藥的興趣日益濃厚所推動的。然而，建立生物相似藥生產設施所需的高資本投資以及嚴格的生物相似藥監管標準對參與企業構成了挑戰。另一方面，亞太地區和拉丁美洲等新興市場憑藉發達的醫療保健基礎設施和患者更容易獲得生物相似藥，提供了巨大的收益潛力。合約製造商有機會提供從細胞株開發到生物相似藥商業製造的端到端服務，並幫助市場開發。

本研究的主要特點

本報告對全球生物相似藥契約製造市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模（以十億美元為單位）和年複合成長率（CAGR%），假設 2024 年為基準年。

它還強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。

全球生物相似藥契約製造市場的主要企業是根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行的分析。

研究涉及的主要企業包括 Biocon、安進、輝瑞、勃林格殷格翰、龍沙、康泰倫特、無錫生物技術有限公司、艾伯維、默克、Rentschler Biopharma、Almac Group、富士 Diosynth Biotechnologies、贏創工業、Avid Bioservices 等。

本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、高階市場策略、市場擴張和行銷策略做出明智的決策。

全球生物相似契約製造市場報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

可以透過用於分析全球生物相似藥契約製造市場的各種策略矩陣來促進相關人員的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 12.42 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	16.10%	2032 Value Projection:	USD 35.35 Bn

Biosimilars are biological products designed to have highly similar therapeutic effect to an already approved biologic product, known as the reference product or originator product. With the patent expiry of several blockbuster biologics, biosimilars provide an opportunity for patient access to more affordable healthcare. Contract manufacturing organizations (CMOs) aid pharmaceutical companies in manufacturing biosimilars to exacting quality standards through process development and scaling up. Offloading biosimilar manufacturing to CMOs allows drug makers to focus on core competencies such as R&D.

Market Dynamics:

The global biosimilar contract manufacturing market growth is driven by the growing demand for affordable biosimilars due to patent expiration of biologics and increasing focus on biosimilars due to their cost-effectiveness. However, high capital investment requirements for setting up biosimilar manufacturing facilities and stringent regulatory standards for biosimilars pose challenges to market players. On the other hand, emerging markets, such as Asia Pacific and Latin America, present significant revenue potential with improving healthcare infrastructure and patient access to biosimilars in these regions. Contract manufacturers have opportunities to provide end-to-end services from cell line development to commercial manufacturing of biosimilars and help expand market reach.

Key Features of the Study:

This report provides in-depth analysis of the global biosimilar contract manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global biosimilar contract manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Biocon, Amgen, Pfizer, Boehringer Ingelheim, Lonza, Catalent, Wuxi Biologics, AbbVie, Merck KGaA, Rentschler Biopharma, Almac Group, Fujifilm Diosynth Biotechnologies, Evonik Industries, and Avid Bioservices

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global biosimilar contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biosimilar contract manufacturing market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Recombinant Non-glycosylated Proteins
- Recombinant Glycosylated Proteins
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Diabetes
- Infectious Diseases
- Chronic and Autoimmune Disorders
- Blood Disorders
- Growth Hormonal Deficiency
Type Insights (Revenue, USD Bn, 2020 - 2032)
- Mammalian Manufacturing
- Microbial Manufacturing
Service Type Insights (Revenue, USD Bn, 2020 - 2032)
- Upstream Processing
- Downstream Processing
- Biosimilarity testing
- Bioassay (in vitro/in vivo)
- Process Development
- Fill & Finish
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Biopharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Biocon
- Amgen
- Pfizer
- Boehringer Ingelheim
- Lonza
- Catalent
- Wuxi Biologics
- AbbVie
- Merck KGaA
- Rentschler Biopharma
- Almac Group
- Fujifilm Diosynth Biotechnologies
- Evonik Industries
- Avid Bioservices

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Biosimilar Contract Manufacturing Market, By Product Type
- Global Biosimilar Contract Manufacturing Market, By Application
- Global Biosimilar Contract Manufacturing Market, By Type
- Global Biosimilar Contract Manufacturing Market, By Service Type
- Global Biosimilar Contract Manufacturing Market, By End User
- Global Biosimilar Contract Manufacturing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends

4. Global Biosimilar Contract Manufacturing Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Recombinant Non-glycosylated Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Recombinant Glycosylated Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Biosimilar Contract Manufacturing Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic and Autoimmune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Growth Hormonal Deficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Biosimilar Contract Manufacturing Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Mammalian Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Microbial Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Biosimilar Contract Manufacturing Market, By Service Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Upstream Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Downstream Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biosimilarity testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Bioassay (in vitro/in vivo)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Process Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fill & Finish
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Biosimilar Contract Manufacturing Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Contract Manufacturing Organizations (CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Biosimilar Contract Manufacturing Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Samsung Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biocon
Amgen
Pfizer
Boehringer Ingelheim
Lonza
Catalent
Wuxi Biologics
AbbVie
Merck KGaA
Rentschler Biopharma
Almac Group
Fujifilm Diosynth Biotechnologies
Evonik Industries
Avid Bioservices